Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,333.60
(
-0.08%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
107.06
(
-0.39%
)
Bitcoin
76,896.07
(
-0.66%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 54
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: xrymd post# 105349

Wednesday, 09/29/2010 1:08:08 PM

Wednesday, September 29, 2010 1:08:08 PM

Post# of 257580
PYMX -- PMX-60056 is not the drug to get excited about. The drug to get excited about is PMX-30063. The trial just initiated provides the first look in target (non-healthy) patients so this is early, but the data will be very instructive as it is a head-to-head trial against an active control.

Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today